Tuesday, July 1, 2025 7/1/2025

Biological mechanisms and consequences of efficient extracellular electron transfer in Pseudomonas aeruginosa

Award Number: R01AI127850
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/08/2017
PERIOD OF PERFORMANCE END DATE: 06/30/2028

Group Awards By:

View Award Description

Biological mechanisms and consequences of efficient extracellular electron transfer in Pseudomonas aeruginosa - PROJECT SUMMARY Pseudomonas aeruginosa is an opportunistic pathogen found in acute infections (burns, wounds, ventilator associated pneumonia, eye infections) and chronic infections of the foot (diabetic ulcers) and lung (cystic fibrosis). This bacterium commonly survives in these contexts as a biofilm, the formation and high-level antibiotic tolerance of which interferes with effective patient treatment. A defining aspect of P. aeruginosa is its ability to make pyocyanin, a colorful redox-active pigment that contributes to biofilm development and its fitness in the context of infection. Pyocyanin has been detected at appreciable concentrations in skin wounds and in cystic fibrosis sputum, and pyocyanin has been shown to be a virulence factor in animal infection models. Pyocyanin exerts a range of effects over the cells that produce it, ranging from toxic in the presence of oxygen to beneficial in its absence; under oxygen-limited conditions, pyocyanin serves as an electron acceptor that promotes redox-balancing and long-term survival. These toxic and beneficial roles are important at different times in biofilm development, with early pyocyanin -promoted lysis generating extracellular DNA (eDNA), a key component of the biofilm matrix together with exopolysaccharides. Recently, we determined that eDNA underpins pyocyanin’s ability to promote extracellular electron transfer (EET) within biofilms, facilitating metabolic activity in the oxygen-limited interior. We found that eDNA enables both the retention of pyocyanin and charge transfer to pyocyanin. Critical to making these discoveries was our development of new bioelectrochemical technologies and approaches and the application of advanced spectroscopic techniques to directly probe EET in biofilms. We now seek to extend our interdisciplinary work to gain a mechanistic understanding of how biofilm EET efficiency is tuned by the composition of the matrix and the consequences this may have for antibiotic tolerance. Does the ratio of certain exopolysaccharides (Pel, Psl) to eDNA modulate pyocyanin diffusivity in the matrix, controlling EET efficiency? Does EET efficiency correlate with the rate of redox balancing in the biofilm interior? How do pyocyanin-mediated cellular effects, including EET, contribute to antibiotic tolerance in biofilms, and do these mechanisms differ according to the amount of oxygen in the microenvironment? Does the relative sensitivity of diverse pyocyanin-producing P. aeruginosa isolates to antibiotics correlate with their matrix composition and EET efficiency? Aim1 will explore how the matrix composition, particularly the ratio of Pel and Psl exopolysaccharides to eDNA, determines EET efficiency. Aim 2 will test the hypothesis that pyocyanin is a versatile intrinsic tolerance factor, where PYO-EET helps P. aeruginosa biofilms tolerate mechanistically distinct and clinically important antibiotic classes via bioenergetic effects and/or by inducing defense mechanisms; we predict the dominant mechanism by which PYO impacts tolerance will differ as a function of oxygen concentration. Attainment of these objectives will lay the foundation of basic knowledge necessary to design better strategies to control P. aeruginosa biofilms.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $726,740 )
2025	2025	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	8	6/18/2025	NON-COMPETING CONTINUATION	$726,740
														Subtotal = $726,740

Issue Date FY: 2024 ( Subtotal = $728,326 )
2024	2024	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	7	6/11/2024	NON-COMPETING CONTINUATION	$728,326
														Subtotal = $728,326

Issue Date FY: 2023 ( Subtotal = $747,489 )
2023	2023	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	001	6	7/20/2023	COMPETING CONTINUATION	$747,489
2023	2021	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	5	6/23/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $747,489

Issue Date FY: 2021 ( Subtotal = $523,956 )
2021	2021	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	5	4/23/2021	NON-COMPETING CONTINUATION	$523,956
														Subtotal = $523,956

Issue Date FY: 2020 ( Subtotal = $523,956 )
2020	2020	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	4	4/28/2020	NON-COMPETING CONTINUATION	$523,956
														Subtotal = $523,956

Issue Date FY: 2019 ( Subtotal = $523,956 )
2019	2019	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	3	4/19/2019	NON-COMPETING CONTINUATION	$523,956
														Subtotal = $523,956

Issue Date FY: 2018 ( Subtotal = $523,956 )
2018	2018	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	2	4/17/2018	NON-COMPETING CONTINUATION	$523,956
														Subtotal = $523,956

Issue Date FY: 2017 ( Subtotal = $540,206 )
2017	2017	CALIFORNIA INSTITUTE OF TECHNOLOGY	1200 E CALIFORNIA BLVD	PASADENA	CA	91125	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	1	5/4/2017	NEW	$540,206
														Subtotal = $540,206

Grand Total All Awards = $4,838,585

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Biological mechanisms and consequences of efficient extracellular electron transfer in Pseudomonas aeruginosa

Award Number: R01AI127850

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/08/2017

PERIOD OF PERFORMANCE END DATE: 06/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer